{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T22:14:56Z","timestamp":1757542496941,"version":"3.37.3"},"reference-count":9,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2021,4,8]],"date-time":"2021-04-08T00:00:00Z","timestamp":1617840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,4,8]],"date-time":"2021-04-08T00:00:00Z","timestamp":1617840000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Toxicol"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1007\/s12012-021-09648-z","type":"journal-article","created":{"date-parts":[[2021,4,8]],"date-time":"2021-04-08T05:02:55Z","timestamp":1617858175000},"page":"494-497","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Incessant Atrial Tachycardia Following Combination Chemotherapy with Cetuximab, Cisplatin and 5-Fluorouracil for Hypopharyngeal Cancer"],"prefix":"10.1007","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2260-4166","authenticated-orcid":false,"given":"Yuki","family":"Sahashi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahide","family":"Nawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,4,8]]},"reference":[{"issue":"8","key":"9648_CR1","first-page":"e005443","volume":"10","author":"V Buza","year":"2017","unstructured":"Buza, V., Rajagopalan, B., & Curtis, A. B. (2017). Cancer Treatment-induced arrhythmias: Focus on chemotherapy and targeted therapies. CircArrhythmElectrophysiol, 10(8), e005443.","journal-title":"CircArrhythmElectrophysiol"},{"issue":"25","key":"9648_CR2","doi-asserted-by":"publisher","first-page":"3122","DOI":"10.1161\/01.CIR.0000133187.74800.B9","volume":"109","author":"ET Yeh","year":"2004","unstructured":"Yeh, E. T., Tong, A. T., Lenihan, D. J., Yusuf, S. W., Swafford, J., Champion, C., Durand, J.-B., Gibbs, H., Zafarmand, A. A., & Ewer, M. S. (2004). Cardiovascular complications of cancer therapy: Diagnosis, pathogenesis, and management. Circulation, 109(25), 3122\u20133131.","journal-title":"Circulation"},{"issue":"8","key":"9648_CR3","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1016\/j.ctrv.2013.03.005","volume":"39","author":"A Polk","year":"2013","unstructured":"Polk, A., Vaage-Nilsen, M., Vistisen, K., & Nielsen, D. L. (2013). Cardiotoxicity in cancer patients treated with 5-fluorouracil or capecitabine: A systematic review of incidence, manifestations and predisposing factors. Cancer Treatment Reviews, 39(8), 974\u2013984.","journal-title":"Cancer Treatment Reviews"},{"issue":"17","key":"9648_CR4","doi-asserted-by":"publisher","first-page":"2585","DOI":"10.2165\/00003495-200767170-00008","volume":"67","author":"SK Blick","year":"2007","unstructured":"Blick, S. K., & Scott, L. J. (2007). Cetuximab: A review of its use in squamous cell carcinoma of the head and neck and metastatic colorectal cancer. Drugs, 67(17), 2585\u20132607.","journal-title":"Drugs"},{"key":"9648_CR5","unstructured":"Cetuximab FDA package insert. Available at https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2015\/125084s262lbl.pdf. Accessed 2 May 2017."},{"key":"9648_CR6","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1055\/s-0033-1356164","volume":"35","author":"L Kordelas","year":"2014","unstructured":"Kordelas, L., Bauer, S., Schuler, M., Beelen, D. W., & Gauler, T. C. (2014). Successful resuscitation of a patient with ventricular fibrillation due to hypomagnesemia under cetuximab therapy. TumorDiagnostik & Therapie, 35, 25\u201327.","journal-title":"TumorDiagnostik & Therapie"},{"issue":"6","key":"9648_CR7","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.3892\/ol.2013.1301","volume":"5","author":"P Chen","year":"2013","unstructured":"Chen, P., Wang, L., Li, H., Liu, B., & Zou, Z. (2013). Incidence and risk of hypomagnesemia in advanced cancer patients treated with cetuximab: A meta-analysis. Oncology Letters, 5(6), 1915\u20131920.","journal-title":"Oncology Letters"},{"issue":"2","key":"9648_CR8","first-page":"108","volume":"3","author":"WL Baker","year":"2017","unstructured":"Baker, W. L. (2017). Treating arrhythmias with adjunctive magnesium: identifying future research directions. Eur Heart J CardiovascPharmacother., 3(2), 108\u2013117.","journal-title":"Eur Heart J CardiovascPharmacother."},{"issue":"5","key":"9648_CR9","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1093\/eurheartj\/ehz467","volume":"41","author":"J Brugada","year":"2020","unstructured":"Brugada, J., Katritsis, D. G., Arbelo, E., Arribas, F., Bax, J. J., Blomstr\u00f6m-Lundqvist, C., Calkins, H., Corrado, D., Deftereos, S. G., Diller, G.-P., Gomez-Doblas, J. J., Gorenek, B., Grace, A., Ho, S. Y., Kaski, J.-C., Kuck, K.-H., Lambiase, P. D., Sacher, F., Sarquella-Brugada, G., \u2026 ESC Scientific Document Group. (2020). 2019 ESC Guidelines for the management of patients with supraventricular tachycardia The Task Force for the management of patients with supraventricular tachycardia of the European Society of Cardiology (ESC). Eur Heart J, 41(5), 655\u2013720.","journal-title":"Eur Heart J"}],"container-title":["Cardiovascular Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12012-021-09648-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12012-021-09648-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12012-021-09648-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,26]],"date-time":"2021-04-26T17:20:32Z","timestamp":1619457632000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12012-021-09648-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,8]]},"references-count":9,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["9648"],"URL":"https:\/\/doi.org\/10.1007\/s12012-021-09648-z","relation":{},"ISSN":["1530-7905","1559-0259"],"issn-type":[{"type":"print","value":"1530-7905"},{"type":"electronic","value":"1559-0259"}],"subject":[],"published":{"date-parts":[[2021,4,8]]},"assertion":[{"value":"1 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The patient received informed consent and agreed with the publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}}]}}